Of note, the skewing of the T-cell profile towards circulating CCR4+CXCR3−T-helper subsets, Th2 and Th17 prior to initiating any RA therapy in patients diagnosed with “early” RA suggested that these cells may have a particular role in the beginning stages of RA [24]. This evidence concerns the gene CCR4 and rheumatoid arthritis.